Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.
about
Trabectedin for Soft Tissue Sarcoma: Current Status and Future PerspectivesThe value of trabectedin in the treatment of soft tissue sarcomaTrabectedin for advanced soft tissue sarcomas: optimizing useRecent advances in targeted therapy for Ewing sarcomaTrabectedin in soft tissue sarcomasManagement Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinEcteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cellsA systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcomaNature's bounty - drug discovery from the seaRubrolide R: a new furanone metabolite from the ascidian Synoicum of the Indian Ocean.The evolution of systemic therapy in sarcoma.Trabectedin and its potential in the treatment of soft tissue sarcoma.Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma.Trabectedin for the management of soft-tissue sarcoma.Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group.Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine originAbsence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trial.Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsNeoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.Role of trabectedin in the treatment of soft tissue sarcomaClinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS).Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cellsTrabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group studyLiposarcoma in children and young adults: a multi-institutional experience.Trabectedin: safety and efficacy in the treatment of advanced sarcomaPrognostic factors and metastatic patterns in primary myxoid/round-cell liposarcoma.PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcomaEpidemiology and therapies for metastatic sarcomaEmerging therapies for adult soft tissue sarcoma.Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.Advances in the targeted therapy of liposarcoma.Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsTransarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survivalIdentification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience.Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor.
P2860
Q26745502-9CA59ECB-C06C-475D-B99E-80B1CB1806DCQ26772855-25CDC045-55A8-47C4-B1F2-8C730D41E803Q26860365-E05D3FCF-0E4E-4222-9CA5-A04ADD957D98Q28079316-7C31E880-C4FF-4EB0-9FA8-E45439B2E5B1Q28085505-229E5F56-FA4F-478A-B70D-16F8A2E28ED3Q28087771-E580D9BD-1F11-4CAC-8B6F-176174F02F87Q28307320-04DA311D-146C-49BD-8273-A6DCC4ACC45CQ28482357-685308D6-95BC-4A69-AC5E-6CB01DFC8DD9Q28828257-021299B8-D54A-4727-90AD-695BD721752AQ30662541-9059B8FB-ABD1-49D0-868E-0E8C66FFBBA7Q33274710-F6D43CC0-7CE3-4482-AF83-4DDECBC795ADQ33380903-D9312CB0-397D-4383-A3B2-6C76D04EA275Q33381641-EE846F99-8B46-4852-A4CB-8F38F19B0104Q33384836-E089232A-10F0-478B-A0E5-5724AA67BCEFQ33426789-1DFBDF28-8267-41E9-B86D-1A52E6A510DDQ33523297-95822200-75EE-469C-834A-0CB7810259BBQ33561602-C1EF448B-AA95-4F10-88FF-7C0C6EAC887CQ33648002-CF19AB56-D635-414B-A97C-7DFED79A125FQ33649056-F7652184-6BFA-4687-BCBF-596CB93BB52BQ33757142-B33C7B83-3A71-4C66-A5A9-EEE88E0877CEQ33916011-4B45341E-B987-4F5D-B727-797984DC387AQ34045393-162A1B14-72C4-4496-A99A-40F8F0F62EF6Q34202863-D33A20DA-DFDF-4E82-AFC4-71D57AC870E1Q34356540-852E37E7-65E3-4AC6-865E-3B56A30EA5C3Q34413659-CAA5DDBA-6873-4C21-8D5C-3442CEA7173CQ34627494-15100AE2-BFF4-4C56-B91D-888A3C630427Q34628607-EE282DE1-7E61-4786-9AA1-96A7AA803B84Q34634538-5C498C71-135A-494F-AB3E-C601D8AC3A31Q34635550-477C9B7F-B34B-42AC-B7F4-829F19682B7BQ34652142-8E64977F-EEFE-44E4-B668-C2D1DA41F84BQ34659806-01006F06-B8FF-41DF-BD37-E7E52E36B5ADQ34664479-3B3E1B43-C9BE-44C0-A8E7-88BBF24015B6Q34674564-CAD2D510-1D48-4E5F-96FE-53293274E531Q34736667-09489DD4-4A93-4CAF-A3AF-BC95B06466AFQ34952133-9D983971-F7C7-48D2-8726-E9F11BF9DF5BQ35013284-DE651C74-B584-470A-B1CD-D256C9ED142CQ35044274-8EC80729-EB33-47C7-89AD-8A03863B2118Q35058617-95085220-68F2-44F7-BAB0-A327C6E34EEDQ35060225-D0F82C71-C4F4-4512-B0F5-8D4109BBD66FQ35103320-BEC8E99B-E49A-4A2B-9A83-4A91D565491D
P2860
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Efficacy of trabectedin (ectei ...... rcomas: a retrospective study.
@en
type
label
Efficacy of trabectedin (ectei ...... rcomas: a retrospective study.
@en
prefLabel
Efficacy of trabectedin (ectei ...... rcomas: a retrospective study.
@en
P2093
P50
P1433
P1476
Efficacy of trabectedin (ectei ...... rcomas: a retrospective study.
@en
P2093
Federica Grosso
George D Demetri
Ian R Judson
Jonathan A Fletcher
Josè Jimeno
Juan Carlos Tercero
Palma Dileo
Paola Casieri
Robin L Jones
Silvana Pilotti
P304
P356
10.1016/S1470-2045(07)70175-4
P50
P577
2007-07-01T00:00:00Z